Ethics Approval for Cynata’s Clinical Trial in Diabetic Foot Ulcers
30 juin 2021 08h56 HE
|
Cynata Therapeutics Limited
Key highlights Ethics approval received for clinical trial in patients with diabetic foot ulcers First clinical trial to utilise the wound dressing technology recently licensed from TekCyte Patient...
Cynata signs Licence Agreement with TekCyte to advance Clinical Trial in Diabetic Foot Ulcers
03 juin 2021 08h00 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, June 03, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell...
First Patient Enrolled in Cynata’s MEND Clinical Trial
24 mai 2021 08h00 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, May 24, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics,...
Cynata Expands MEND clinical trial in COVID-19 and Respiratory Failure
29 mars 2021 08h00 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, March 29, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that...
New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs
02 mars 2021 08h00 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, March 02, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell...
Cynata Advances Planned Clinical Trial in Diabetic Foot Ulcers in MoU With TekCyte
01 mars 2021 08h00 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, March 01, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell...
Cynata Secures $15m Placement Led By $10m from Healthcare Investor BioScience Managers to Expand Development Pipeline
11 déc. 2020 08h00 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell...
Phase 3 Osteoarthritis Clinical Trial Commences
11 nov. 2020 08h00 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell...
Cymerus MSCs Demonstrate Efficacy in Preclinical Lung Disease Study
08 sept. 2020 08h05 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell...
Patient Enrolment Opens in COVID-19 Clinical Trial
24 août 2020 08h05 HE
|
Cynata Therapeutics Limited
MELBOURNE, Australia, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology company specialising in cell therapeutics, is pleased to...